| Bioactivity | AGI-41998 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). AGI-41998 is a brain-penetrant compound. AGI-41998 has the potential for exploring the effects of SAM modulation in the central nervous system (CNS) and research of cancer disease[1]. | |||||||||
| Name | AGI-41998 | |||||||||
| CAS | 2377492-26-5 | |||||||||
| Formula | C22H16BrF3N4O2 | |||||||||
| Molar Mass | 505.29 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Li M, et al. Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. J Med Chem. 2022;65(6):4600-4615. |
AGI-41998
CAS: 2377492-26-5 F: C22H16BrF3N4O2 W: 505.29
AGI-41998 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). AGI-41998 is a brain-penetrant compound. A
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.